IL2 and neoplasm: Efficient tumor-lytic activity after pharmacologic Vδ2 TCR-stimulation correlates with granzyme B and IFN-γ/TNF-α production in γδ T cells, parameters which we and others found to be enhanced when IL-2, IL-12, and IL-18 are added [16,17,18,19].